Nevro Corp (NVRO)
5.29
+0.09
(+1.73%)
USD |
NYSE |
Sep 27, 16:00
5.285
0.00 (0.00%)
Pre-Market: 20:00
Nevro Research and Development Expense (TTM): 55.29M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 55.29M |
| March 31, 2024 | 54.49M |
| December 31, 2023 | 54.42M |
| September 30, 2023 | 55.94M |
| June 30, 2023 | 56.05M |
| March 31, 2023 | 55.28M |
| December 31, 2022 | 53.06M |
| September 30, 2022 | 51.83M |
| June 30, 2022 | 49.35M |
| March 31, 2022 | 48.67M |
| December 31, 2021 | 47.66M |
| September 30, 2021 | 46.79M |
| June 30, 2021 | 46.35M |
| March 31, 2021 | 44.92M |
| December 31, 2020 | 45.60M |
| September 30, 2020 | 50.70M |
| June 30, 2020 | 52.61M |
| March 31, 2020 | 57.09M |
| December 31, 2019 | 59.02M |
| September 30, 2019 | 55.56M |
| June 30, 2019 | 55.02M |
| Date | Value |
|---|---|
| March 31, 2019 | 51.51M |
| December 31, 2018 | 48.46M |
| September 30, 2018 | 44.92M |
| June 30, 2018 | 41.82M |
| March 31, 2018 | 39.95M |
| December 31, 2017 | 37.56M |
| September 30, 2017 | 38.89M |
| June 30, 2017 | 37.44M |
| March 31, 2017 | 36.07M |
| December 31, 2016 | 33.73M |
| September 30, 2016 | 28.33M |
| June 30, 2016 | 25.65M |
| March 31, 2016 | 22.74M |
| December 31, 2015 | 21.38M |
| September 30, 2015 | 20.25M |
| June 30, 2015 | 20.24M |
| March 31, 2015 | 20.13M |
| December 31, 2014 | 19.82M |
| September 30, 2014 | 19.72M |
| June 30, 2014 | 19.07M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
44.92M
Minimum
Mar 2021
59.02M
Maximum
Dec 2019
52.03M
Average
52.84M
Median
Research and Development Expense (TTM) Benchmarks
| Myomo Inc | 3.559M |
| Inspire Medical Systems Inc | 117.90M |
| Axonics Inc | 41.73M |
| Inari Medical Inc | 96.17M |
| Electromed Inc | 0.656M |